Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Apoptosis and catastrophic cell death in benzo[a]pyrene-transformed human breast epithelial cells
Author: Barbisan, LF
Mello, MLS
Russo, J
Vidal, BD
Abstract: Apoptosis and mitotic death, bi- and multinucleation, giant cells and micronucleation were investigated in human breast epithelial cell lines transformed by benzo[a]pyrene (BP) (BP1, BP1-E and BP1-E1 cells) and in BP1 cells transfected with the c-aa-ras oncogene (BP1-Tras cells). Since BP induces apoptosis and the abnormal expression of ras genes elicits catastrophic mitosis, both cell death phenomena were expected to occur in this system, especially in BP1-Tras cells. Regardless of the cell line considered, single-nucleate cells were found to be eliminated preferentially through apoptosis, while bi- and multinucleate cells were eliminated through catastrophic mitosis. Apoptosis and catastrophic mitosis were observed in all cell lines but were significantly more frequent in BP1-Tras cells. The abnormal expression of Ha-ras in the latter cells may enhance in this system the effects of the BP apoptosis path reported for BP-transformed Hepa 1c1c7 hepatoma cells. Transfection with the ras oncogene also enhanced the mitotic disturbances, which produced multi- and micronucleation and mitotic death, possibly because of the genomic instability promoted by this oncogene in the BP-transformed cell line. (C) 1999 Elsevier Science B.V. All rights reserved.
Subject: benzo[a]pyrene
mitotic death
human breast epithelial cells
Country: Holanda
Editor: Elsevier Science Bv
Citation: Mutation Research-fundamental And Molecular Mechanisms Of Mutagenesis. Elsevier Science Bv, v. 431, n. 1, n. 133, n. 139, 1999.
Rights: fechado
Identifier DOI: 10.1016/S0027-5107(99)00193-1
Date Issue: 1999
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000084787600013.pdf494.89 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.